FDA inspection
BF Suma Pharmaceuticals, Inc.: FDA inspection ending Feb 14, 2024
FDA inspection 1230617 · Voluntary Action Indicated (VAI) · Rosemead, CA
Key facts
| Inspection ID | 1230617 |
|---|---|
| Firm | BF Suma Pharmaceuticals, Inc. |
| FEI number | 3006316986 |
| Address | 5001 Earle Ave |
| City | Rosemead |
| State | CA |
| ZIP | 91770 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Feb 14, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Food Composition, Standards, Labeling and Econ |
| Product type | Food/Cosmetics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data